Montana Molecular
Private Company
Total funding raised: $11.5M
Overview
Founded in 2009 and based in Bozeman, Montana, Montana Molecular has established itself as a specialized provider of live-cell fluorescent biosensor assays and related viral delivery tools. Its core technology platform utilizes BacMam gene delivery to express genetically encoded biosensors in a wide range of cell types, enabling high-content imaging and functional analysis for academic and industrial drug discovery. The company operates primarily as a tools and services provider, generating revenue through product kits, custom viral vector services, and assay support, positioning it as an enabler for early-stage research and target validation.
Technology Platform
Genetically encoded fluorescent biosensors (e.g., for cAMP, DAG, arrestin, cell stress) delivered via BacMam viral vectors for real-time, live-cell imaging and analysis of signaling pathways.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Competes with large reagent suppliers (e.g., Thermo Fisher, Revvity) offering broad assay portfolios and with academic labs that publish novel biosensors. Differentiates through specialized expertise in BacMam delivery, a focused product line for signaling pathways, and strong technical support and custom service capabilities.